ABOUT THIS PODCAST
Congress and federal agencies are considering significant changes to the 340B program, while implementation of the Inflation Reduction Act’s Medicare drug price negotiation provisions continues to raise important questions for hospitals and health systems. We’ll provide an update on the latest legislative and regulatory developments, the intersection of IRA implementation and the HRSA 340B rebate pilot, and what to expect from Congress and federal agencies in the months ahead.
SPEAKERS
- Frank Kolb, JD, MPH
Director, Federal Legislative Affairs
ASHP - Jillanne Schulte Wall, JD
Senior Director, Health & Regulatory Policy
ASHP - Tom Kraus, JD
Chief Advocacy Officer and Vice President, Government Relations
ASHP





